Susan E Trompeter1, Ricki Bettencourt2, Elizabeth Barrett-Connor3. 1. Division of General Internal Medicine, Department of Medicine, University of California, San Diego, La Jolla, California; Veterans Affairs San Diego Healthcare System, San Diego, California. 2. Division of Epidemiology, Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, California. 3. Division of Epidemiology, Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, California. Electronic address: ebarrettconnor@ucsd.edu.
Abstract
BACKGROUND: Limited literature suggests that sexual dysfunction in women covaries with the metabolic syndrome. This study examined the association of sexual function with metabolic syndrome and cardiovascular disease in healthy older women. METHODS: There were 376 postmenopausal, community-dwelling women from the Rancho Bernardo Study (mean baseline age = 73 years) that completed a clinic visit during 1999-2002 and returned the Female Sexual Function Index (FSFI) questionnaire mailed in 2002. RESULTS: Thirty-nine percent reported being sexually active; 41.5% met a diagnosis of metabolic syndrome. The number of metabolic syndrome components was strongly associated with decreased sexual activity, desire, and low sexual satisfaction. Waist girth, diabetes, and hypertension were associated with decreased sexual activity. Elevated triglycerides were associated with low desire. Among the cardiovascular endpoints, heart attack, coronary artery bypass, and angina were associated with decreased sexual activity, but not with sexual desire or satisfaction. Past diagnosis of heart failure, poor circulation, and stroke were not associated with sexual function. Sexually active women with metabolic syndrome met criteria for sexual dysfunction in desire, arousal, orgasm, and satisfaction domains. The FSFI Total Score did not differ significantly between sexually active and inactive women. CONCLUSIONS: Metabolic syndrome was associated with decreased sexual activity, desire, and satisfaction in all women and with sexual dysfunction in most domains in sexually active women. Coronary artery disease was more prevalent in women with low sexual activity.
BACKGROUND: Limited literature suggests that sexual dysfunction in women covaries with the metabolic syndrome. This study examined the association of sexual function with metabolic syndrome and cardiovascular disease in healthy older women. METHODS: There were 376 postmenopausal, community-dwelling women from the Rancho Bernardo Study (mean baseline age = 73 years) that completed a clinic visit during 1999-2002 and returned the Female Sexual Function Index (FSFI) questionnaire mailed in 2002. RESULTS: Thirty-nine percent reported being sexually active; 41.5% met a diagnosis of metabolic syndrome. The number of metabolic syndrome components was strongly associated with decreased sexual activity, desire, and low sexual satisfaction. Waist girth, diabetes, and hypertension were associated with decreased sexual activity. Elevated triglycerides were associated with low desire. Among the cardiovascular endpoints, heart attack, coronary artery bypass, and angina were associated with decreased sexual activity, but not with sexual desire or satisfaction. Past diagnosis of heart failure, poor circulation, and stroke were not associated with sexual function. Sexually active women with metabolic syndrome met criteria for sexual dysfunction in desire, arousal, orgasm, and satisfaction domains. The FSFI Total Score did not differ significantly between sexually active and inactive women. CONCLUSIONS:Metabolic syndrome was associated with decreased sexual activity, desire, and satisfaction in all women and with sexual dysfunction in most domains in sexually active women. Coronary artery disease was more prevalent in women with low sexual activity.
Authors: Rachel P Wildman; Ping G Tepper; Sybil Crawford; Joel S Finkelstein; Kim Sutton-Tyrrell; Rebecca C Thurston; Nanette Santoro; Barbara Sternfeld; Gail A Greendale Journal: J Clin Endocrinol Metab Date: 2012-06-21 Impact factor: 5.958
Authors: Ilana B Addis; Christine C Ireland; Eric Vittinghoff; Feng Lin; Cynthia A Stuenkel; Stephen Hulley Journal: Obstet Gynecol Date: 2005-07 Impact factor: 7.661
Authors: Francesco Giugliano; Maria Ida Maiorino; Carmen Di Palo; Riccardo Autorino; Marco De Sio; Dario Giugliano; Katherine Esposito Journal: J Sex Med Date: 2010-02-25 Impact factor: 3.802
Authors: Stephanie S Faubion; Flavia Fairbanks; Carol L Kuhle; Richa Sood; Juliana M Kling; Jennifer A Vencill; Kristin C Mara; Ekta Kapoor Journal: J Sex Med Date: 2020-08-06 Impact factor: 3.802
Authors: Gustavo Maximiliano Dutra da Silva; Sônia Maria Rolim Rosa Lima; Benedito F Reis; Carolina Furtado Macruz; Sóstenes Postigo Journal: Sex Med Date: 2020-06-24 Impact factor: 2.491
Authors: Helena Harder; Rachel M L Starkings; Lesley J Fallowfield; Usha Menon; Ian J Jacobs; Valerie A Jenkins Journal: Menopause Date: 2019-10 Impact factor: 2.953
Authors: I Scavello; E Maseroli; S Cipriani; V Di Stasi; N Verde; D Menafra; S Scannerini; S Marchiani; G Rastrelli; V Ricca; F Sorbi; M Fambrini; F Petraglia; M Maggi; Linda Vignozzi Journal: Sci Rep Date: 2021-09-22 Impact factor: 4.379
Authors: Małgorzata Kałużna; Agnieszka Nomejko; Aleksandra Słowińska; Katarzyna Wachowiak-Ochmańska; Katarzyna Pikosz; Katarzyna Ziemnicka; Marek Ruchała Journal: Endocr Connect Date: 2021-08-30 Impact factor: 3.335